Literature DB >> 7685415

Alterations of the three short open reading frames in the Rous sarcoma virus leader RNA modulate viral replication and gene expression.

A Moustakas1, T S Sonstegard, P B Hackett.   

Abstract

The Rous sarcoma virus (RSV) leader RNA has three short open reading frames (ORF1 to ORF3) which are conserved in all avian sarcoma-leukosis retroviruses. Effects on virus propagation were determined following three types of alterations in the ORFs: (i) replacement of AUG initiation codons in order to prohibit ORF translation, (ii) alterations of the codon context around the AUG initiation codon to enhance translation of the normally silent ORF3, and (iii) elongation of the ORF coding sequences. Mutagenesis of the AUG codons for ORF1 and ORF2 (AUG1 and AUG2) singly or together delayed the onset of viral replication and cell transformation. In contrast, mutagenesis of AUG3 almost completely suppressed these viral activities. Mutagenesis of ORF3 to enhance its translation inhibited viral propagation. When the mutant ORF3 included an additional frameshift mutation which extended the ORF beyond the initiation site for the gag, gag-pol, and env proteins, host cells were initially transformed but died soon thereafter. Elongation of ORF1 from 7 to 62 codons led to the accumulation of transformation-defective virus with a delayed onset of replication. In contrast, viruses with elongation of ORF1 from 7 to 30 codons, ORF2 from 16 to 48 codons, or ORF3 from 9 to 64 codons, without any alterations in the AUG context, exhibited wild-type phenotypes. These results are consistent with a model that translation of the ORFs is necessary to facilitate virus production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685415      PMCID: PMC237804     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Biological techniques for avian sarcoma viruses.

Authors:  E Hunter
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Surface ruffles as markers for studies of cell transformation by Rous sarcoma virus.

Authors:  V R Ambros; L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

3.  Changes in microfilament organization and surface topogrophy upon transformation of chick embryo fibroblasts with Rous sarcoma virus.

Authors:  E Wang; A R Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Characterization of ribosome binding on Rous sarcoma virus RNA in vitro.

Authors:  R B Petersen; P B Hackett
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

5.  Partial resistance of nascent polypeptide chains to proteolytic digestion due to ribosomal shielding.

Authors:  L I Malkin; A Rich
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  A new pathway in the generation of defective retrovirus DNA.

Authors:  J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85.

Authors:  A J Dorner; J M Coffin
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

8.  Suppression of multiplication of avian sarcoma virus by rapid spread of transformation-defective virus of the same subgroup.

Authors:  L F Estis; H M Temin
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus.

Authors:  S K Weller; A E Joy; H M Temin
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  Role of the open reading frames of Rous sarcoma virus leader RNA in translation and genome packaging.

Authors:  O Donzé; P F Spahr
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  20 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal.

Authors:  J D Banks; M L Linial
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop.

Authors:  J T Miller; Z Ge; S Morris; K Das; J Leis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  A minimal avian retroviral packaging sequence has a complex structure.

Authors:  J D Banks; A Yeo; K Green; F Cepeda; M L Linial
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 6.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

Review 7.  Avian retroviral replication.

Authors:  James Justice; Karen L Beemon
Journal:  Curr Opin Virol       Date:  2013-09-04       Impact factor: 7.090

8.  A base-paired structure in the avian sarcoma virus 5' leader is required for efficient encapsidation of RNA.

Authors:  J B Knight; Z H Si; C M Stoltzfus
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  The first and third uORFs in RSV leader RNA are efficiently translated: implications for translational regulation and viral RNA packaging.

Authors:  O Donzé; P Damay; P F Spahr
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

10.  Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.

Authors:  Jing Zhou; Rebecca L Bean; Volker M Vogt; Michael Summers
Journal:  J Mol Biol       Date:  2006-10-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.